BRIEF published on 07/02/2026 at 18:35, 14 days 22 hours ago Current status of MaaT Pharma shares and voting rights Euronext Paris Voting Rights Biotechnology Actions MaaT Pharma
BRIEF published on 07/02/2026 at 18:35, 14 days 22 hours ago Situation actuelle des actions et droits de vote de MaaT Pharma Euronext Paris Droits De Vote Biotechnologie Actions MaaT Pharma
PRESS RELEASE published on 07/02/2026 at 18:30, 14 days 22 hours ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital MaaT Pharma publie le nombre total d'actions et de droits de vote au 30 juin 2026 conformément à l'article 223-16 du Règlement Général de l'AMF Droits De Vote Capital Social AMF MaaT Pharma Biotechnologies
BRIEF published on 06/30/2026 at 13:13, 17 days 3 hours ago La demande d'autorisation de mise sur le marché du MaaT013 de MaaT Pharma subit un revers. Maladie Du Greffon Contre L'hôte MaaT Pharma Décision Du CHMP Application Marketing Appel En Réexamen
BRIEF published on 06/30/2026 at 13:13, 17 days 3 hours ago MaaT Pharma's Marketing Application for MaaT013 Faces Setback Graft-versus-Host Disease MaaT Pharma CHMP Decision Marketing Application Re-examination Appeal
PRESS RELEASE published on 06/30/2026 at 13:08, 17 days 4 hours ago Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): Under review First Berlin Equity Research updates rating and price target for MaaT Pharma SACA after CHMP's negative opinion on MAA for MaaT013 in aGvHD First Berlin Equity Research CHMP AGvHD MaaT Pharma SACA MAA
BRIEF published on 06/26/2026 at 07:35, 21 days 9 hours ago MaaT Pharma va contester le verdict négatif du CHMP concernant MaaT013 Thérapies Écosystémiques Du Microbiome MaaT Pharma Maladie Aiguë Du Greffon Contre L'hôte MaaT013 Xervyteg Réexamen CHMP
BRIEF published on 06/26/2026 at 07:35, 21 days 9 hours ago MaaT Pharma to Challenge Negative CHMP Verdict for MaaT013 Microbiome Ecosystem Therapies MaaT Pharma Acute Graft-versus-Host Disease CHMP Re-examination MaaT013 Xervyteg
PRESS RELEASE published on 06/26/2026 at 07:30, 21 days 9 hours ago Inside Information / Other news releases MaaT Pharma to request re-examination by CHMP after negative opinion on MaaT013 for acute Graft-versus-Host Disease treatment. Company plans second opinion during September 2026 session Graft-versus-Host Disease MaaT Pharma CHMP MaaT013 Re-examination
PRESS RELEASE published on 06/26/2026 at 07:30, 21 days 9 hours ago Informations privilégiées / Autres communiqués MaaT Pharma annonce un réexamen suite à l'avis négatif du CHMP concernant MaaT013 dans le traitement de la maladie aiguë du greffon contre l’hôte Traitement MaaT Pharma CHMP MaaT013 Réexamen
Published on 07/17/2026 at 15:00, 2 hours 12 minutes ago Four Nines Gold to Showcase Hayden Hill Opportunity to U.S. Investors at OTC Markets Virtual Investor Conference
Published on 07/17/2026 at 14:00, 3 hours 12 minutes ago Redwood AI Announces Pricing of $3.5 Million Private Placement
Published on 07/17/2026 at 13:00, 4 hours 12 minutes ago Blue Lagoon Surpasses $10 Million In Revenue As Dome Mountain Production Rises To 125 Tonnes Per Day
Published on 07/17/2026 at 01:00, 16 hours 12 minutes ago RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000
Published on 07/17/2026 at 00:00, 17 hours 12 minutes ago LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline
Published on 07/17/2026 at 15:21, 1 hour 50 minutes ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Published on 07/17/2026 at 15:20, 1 hour 51 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 07/17/2026 at 15:20, 1 hour 51 minutes ago Once Human Sets August 25 Launch Date on PS5 and XBOX with New First-Person Perspective and Full Crossplay
Published on 07/17/2026 at 15:19, 1 hour 52 minutes ago Form 8.3 - The Vanguard Group, Inc.: Rotork plc
Published on 07/17/2026 at 15:19, 1 hour 52 minutes ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 07/16/2026 at 18:08, 23 hours 3 minutes ago Aéroports de Paris S.A - June and half-year 2026 traffic figures
Published on 07/16/2026 at 18:08, 23 hours 3 minutes ago Aéroports de Paris S.A - Trafic du mois de juin et du 1er semestre 2026
